SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Bionano Genomics (NASDAQ:BNGO), Inc., a company specializing in laboratory analytical instruments, has terminated a material definitive agreement with Cowen and Company, LLC. This termination, ...

An update from BioNano Genomics ( (BNGO)) is now available. On January 24, 2025, Bionano Genomics, Inc. executed a reverse stock split at a 1-for-60 ratio following approval in a special ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

19:50 EST Bionano Genomics (BNGO) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best ...

After hours: 14 February at 19:59:24 GMT-5 ...

Financials are currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.